Similar articles

• Substitution of glycine-172 by arginine in the alpha 1 chain of type I collagen in a patient with osteogenesis imperfecta, type III.

  Mackay K, De Paepe A, Nuytinck L, Dalgleish R. Mackay K, et al. Hum Mutat. 1994;3(3):324-6. doi: 10.1002/humu.1380030327. Hum Mutat. 1994. PMID: 8019571 No abstract available.
• Substitution of arginine for glycine at position 154 of the alpha 1 chain of type I collagen in a variant of osteogenesis imperfecta: comparison to previous cases with the same mutation.

  Zhuang J, Tromp G, Kuivaniemi H, Castells S, Prockop DJ. Zhuang J, et al. Am J Med Genet. 1996 Jan 11;61(2):111-16. doi: 10.1002/(SICI)1096-8628(19960111)61:2<111::AID-AJMG1>3.0.CO;2-#. Am J Med Genet. 1996. PMID: 8669434
• A Gly859Ser substitution in the triple helical domain of the alpha 2 chain of type I collagen resulting in osteogenesis imperfecta type III in two unrelated individuals.

  Rose NJ, Mackay K, Byers PH, Dalgleish R. Rose NJ, et al. Hum Mutat. 1994;3(4):391-4. doi: 10.1002/humu.1380030411. Hum Mutat. 1994. PMID: 8081394 No abstract available.
• Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta.

  Dyne KM, Valli M, Forlino A, Mottes M, Kresse H, Cetta G. Dyne KM, et al. Am J Med Genet. 1996 May 3;63(1):161-6. doi: 10.1002/(SICI)1096-8628(19960503)63:1<161::AID-AJMG28>3.0.CO;2-L. Am J Med Genet. 1996. PMID: 8723103 Review.
• Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.

  Bächinger HP, Morris NP, Davis JM. Bächinger HP, et al. Am J Med Genet. 1993 Jan 15;45(2):152-62. doi: 10.1002/ajmg.1320450204. Am J Med Genet. 1993. PMID: 8456797 Review.